MIRA INFORM REPORT

 

 

Report Date :

25.06.2012

 

IDENTIFICATION DETAILS

 

Name :

APOLLO HOSPITALS ENTERPRISE LIMITED

 

 

Registered Office :

19 Bishop Gardens, R A Puram, Chennai 600028, Tamil Nadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

05.12.1979

 

 

Com. Reg. No.:

008035

 

 

Capital Investment / Paid-up Capital :

Rs. 623.550 millions

 

 

CIN No.:

[Company Identification No.]

L85110TN1979PLC008035

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHEA00465D / CHEA09347C  / CHEA08844D

 

 

PAN No.:

[Permanent Account No.]

AAACA5443N

 

 

Legal Form :

A Public Limited Liability Company, Company's Shares are Listed on Stock Exchange

 

 

Line of Business :

Providing Healthcare Services.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Aa (71)

 

RATING

STATUS

PROPOSED CREDIT LINE

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

 

Maximum Credit Limit :

USD 70886600

 

 

Status :

Excellent

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed health care service provider company having excellent track. Financial position of the company appears to be sound. Fundamentals are strong and healthy. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

It can be regarded as a promising business partner in medium to long run.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office :

19 Bishop Gardens, Raja Annamalaipuram, Chennai 600028, Tamil Nadu, India 

Tel. No.:

Not Available

Fax No.:

Not Available

E-Mail :

apolloshres@vsnl.net

krishnan_sm@apollohospitals.com

Website :

www.apollohospitals.com

 

 

Administrative Office :

Ali Towers, III Floor, No. 55 Greams Road, Chennai - 600 006, Tamilnadu, India

Tel. No.:

91-44-28290956 / 28293896

Fax No.:

91-44-28290956

 

 

DIRECTORS

 

As on 31.03.2011

 

Name :

Mr. K. Padmanabhan

Designation :

Group President

 

 

Name :

Mr. Krishnan Akhileswaran

Designation :

Chief Financial Officer

 

 

Name :

Mr. S.K. Venkataraman

Designation :

Chief Strategy Officer

 

 

Name :

Dr. Prathap Reddy

Designation :

Executive Chairman

 

 

Name :

Mr. T K Balaji

Designation :

Director

 

 

Name :

Mr. Deepak Vaidya

Designation :

Director

 

 

Name :

Mr. Habibullah Badsha

Designation :

Director

 

 

Name :

Mr. Khairil Anuar Abdullah

Designation :

Director

 

 

Name :

Mrs. Preetha Reddy

Designation :

Director

 

 

Name :

Mr. Rafeeque Ahamed

Designation :

Director

 

 

Name :

Mr. Raj Kumar Menon

Designation :

Director

 

 

Name :

Mr. Sandeep Naik

Designation :

Director

 

 

Name :

Mr. N Vaghul

Designation :

Director

 

 

Name :

Mr. G. Venkatraman

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mr. S.M. Krishnan

Designation :

Company Secretary

 

 

Name :

Mrs. Sangita Reddy

Designation :

Executive Director – Operation

 

 

Name :

Mrs. Shobana Kamineni

Designation :

Executive Director – Special Initiative

 

 

Name :

Mrs. Suneeta Reddy

Designation :

Joint Managing Director

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 31.03.2012

 

Category of Shareholder

Total No. of Shares

Total Shareholding as a % of total No. of Shares

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/images/clear.gifIndividuals / Hindu Undivided Family

23,183,693

17.96

http://www.bseindia.com/images/clear.gifBodies Corporate

21,327,924

16.52

http://www.bseindia.com/images/clear.gifSub Total

44,511,617

34.48

http://www.bseindia.com/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

44,511,617

34.48

(B) Public Shareholding

 

 

http://www.bseindia.com/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/images/clear.gifMutual Funds / UTI

681,422

0.53

http://www.bseindia.com/images/clear.gifFinancial Institutions / Banks

6,136

-

http://www.bseindia.com/images/clear.gifCentral Government / State Government(s)

323,708

0.25

http://www.bseindia.com/images/clear.gifInsurance Companies

2,215,029

1.72

http://www.bseindia.com/images/clear.gifForeign Institutional Investors

53,839,997

41.70

http://www.bseindia.com/images/clear.gifSub Total

57,066,292

44.20

http://www.bseindia.com/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/images/clear.gifBodies Corporate

1,504,443

1.17

http://www.bseindia.com/images/clear.gifIndividuals

 

 

http://www.bseindia.com/images/clear.gifIndividual shareholders holding nominal share capital up to Rs.0.100 Million

7,053,990

5.46

http://www.bseindia.com/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs.0.100 Million

321,466

0.25

http://www.bseindia.com/images/clear.gifAny Others (Specify)

18,653,341

14.45

http://www.bseindia.com/images/clear.gifTrusts

118,470

0.09

http://www.bseindia.com/images/clear.gifDirectors & their Relatives & Friends

91,606

0.07

http://www.bseindia.com/images/clear.gifNon Resident Indians

1,915,405

1.48

http://www.bseindia.com/images/clear.gifOverseas Corporate Bodies

16,199

0.01

http://www.bseindia.com/images/clear.gifClearing Members

57,112

0.04

http://www.bseindia.com/images/clear.gifHindu Undivided Families

122,675

0.10

http://www.bseindia.com/images/clear.gifForeign Corporate Bodies

16,331,874

12.65

http://www.bseindia.com/images/clear.gifSub Total

27,533,240

21.33

Total Public shareholding (B)

84,599,532

65.52

Total (A)+(B)

129,111,149

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

-

-

http://www.bseindia.com/images/clear.gif(1) Promoter and Promoter Group

-

-

http://www.bseindia.com/images/clear.gif(2) Public

5,355,469

-

http://www.bseindia.com/images/clear.gifSub Total

5,355,469

-

Total (A)+(B)+(C)

134,466,618

-

 

 

BUSINESS DETAILS

 

Line of Business :

Providing Healthcare Services.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         Indian Overseas Bank

·         Andhra Bank

·         Canara Bank

·         Indian Bank

·         Bank of India

·         Citibank

·         IDBI Bank

·         HDFC Bank

·         ICICI Bank

·         State Bank of Travancore

·         Axis Bank

·         Oriental Bank of Commerce

·         Standard Chartered Bank

 

 

Facilities :

Rs. In Millions

 

SECURED LOAN

31.03.2011

 

31.03.2010

 

Non-convertible Debentures

 

 

10.3% debentures

1000.000

0.000

Loans and Advances from Banks

 

 

Cash Credit

12.260

0.000

Indian Bank

609.520

952.380

Bank of India

761.900

904.760

Canara Bank

1503.600

2160.000

Other Loans and Advances

 

 

IFC Loan (External Commercial Borrowings)

1608.790

697.160

 

 

 

Total

5496.070

4714.300

 

 

 

UNSECURED LOAN

 

 

Fixed Deposits

579.160

507.520

Short Term Loans and Advances

HDFC

 

1000.000

 

1000.000

Other Loans and Advances

Foreign Currency Convertible Bonds

 

334.880

 

678.050

 

 

 

Total

1914.040

2185.570

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S Viswanatha

Chartered Accountant

Address :

Chennai 600004, Tamilnadu, India

 

 

Subsidiary Companies :

·         Unique Home Health Care Limited

·         AB Medical Centres Limited

·         Samudra Healthcare Enterprise Limited

·         Apollo Hospital UK Limited

·         Apollo Health and Lifestyle Limited

·         Imperial Hospital and Research Centre Limited

·         Pinakini Hospital Limited

·         Apollo Cosmetic Surgical Centre Private Limited

·         Alliance Medicorp India Limited

·         ISIS Healthcare India Private Limited

·         Alliance Dental Care Private Limited

·         Mera Healthcare Private Limited

 

 

Joint Venture :

·         Apollo Gleneagles Hospital Limited

·         Apollo Gleneagles PET-CT Private Limited

·         Western Hospital Corporation Private Limited

·         Apollo Munich Health Insurance Company Limited

·         Apollo Lavasa Health Corporation Limited

·         Quintiles Phase One Clinical Trials India Private Limited

 

 

Associates :

·         Family Health Plan Limited

·         Apollo Health Street Limited

·         Indraprastha Medical Corporation Limited

·         Stemcyte India Therapautics Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 22.07.2011

 

Authorised Capital : Rs.1100.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs.679.241 Millions

 

 

AS ON 31.03.2011

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

200000000

Equity Shares

Rs. 5 each

Rs.1000.000 millions

1000000

Preference  Shares

Rs. 100 each

Rs.100.000 millions

 

Total

 

Rs.1100.000 millions

 

Issued Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

125243728

Equity Shares

Rs. 5 each

Rs.626.220 millions

 

Subscribed & Paid-up Capital : *

 

No. of Shares

Type

Value

Amount

 

 

 

 

124710710

Equity Shares

Rs. 5 each

Rs.623.550 millions

 

A)      Includes 1836596 equity shares of Rs. 5 each fully paid up allotted on conversion of first 2 years interest on debenture, 20% on the face value of debentures and 41624462 equity shares of RS. 5 each fully paid up allotted to the shareholders of amalgamated companies for consideration other than cash.

B)      Includes 4159860 equity shares of Rs. 5 each fully paid up allotted on preferential basis during the year 2004-05.

C)      Includes 3062800 underlying equity shares of Rs. 5 each fully paid up, representing Global Depository Receipts issued during the year 2005-06.

D)      Includes 2079930 equity shares of Rs. 5 each fully paid up allotted during the year 2006-07 on conversion of equity shares warrants issued on preferential basis during the year 2005-06.

E)      Includes 14094238 equity shares of Rs. 5 each fully paid up allotted to Apax Mauritius FDI One limited during the year 2007-08 on preferential basis.

F)      Includes 3100000 equity shares of Rs. 5 each fully paid up allotted during the year 2008-09 on conversion of equity shares warrants issued on preferential basis during the year 2006-07.

G)     Includes 3098314 equity shares of Rs. 5 each fully paid up allotted during the year 2009-10 on conversion of equity shares warrants issued on preferential basis during the year 2007-08.

H)      Includes 1140992 equity shares of Rs. 5 each fully paid up allotted during the year 2010-11 on conversion of FCCBs amounting US $ 7,500,000 issued to International Finance Corporation (IFC), Washington.

 

Equity shares of face value of Rs. 10 each subdivided into 2shares of Rs. 5 each on 3rd September 2010. The number of equity shares allotted prior to 3rd September, 2010 are adjusted to face value of Rs. 5 per shares.

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

623.550

617.850

602.357

2] Preferential Issue of Equity Share Warrants

685.070

0.000

77.099

3] Reserves & Surplus

16413.030

14799.930

13029.112

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

17721.650

15417.780

13708.568

LOAN FUNDS

 

 

 

1] Secured Loans

5496.070

4714.300

4365.524

2] Unsecured Loans

1914.040

2185.570

129.291

TOTAL BORROWING

7410.110

6899.870

4494.815

DEFERRED TAX LIABILITIES

1071.060

751.460

626.560

 

 

 

 

TOTAL

26202.820

23069.110

18829.943

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

10457.510

9240.370

6626.751

Capital work-in-progress

3523.960

2734.120

2372.642

 

 

 

 

INVESTMENT

6241.120

4897.880

6292.795

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

1505.210

1343.440

1088.417

 

Sundry Debtors

2696.430

2055.340

1607.354

 

Cash & Bank Balances

1413.760

2855.580

646.160

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

5714.980

5170.720

3693.223

Total Current Assets

11330.380

11425.080

7035.154

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

1684.240

1781.070

750.048

 

Other Current Liabilities

973.830

848.770

776.957

 

Provisions

2692.080

2598.620

1970.851

Total Current Liabilities

5350.150

5228.460

3497.856

Net Current Assets

5980.230

6196.620

3537.298

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.120

0.457

 

 

 

 

TOTAL

26202.820

23069.110

18829.943

 

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Sales

23319.620

18257.790

14579.776

 

 

Other Income

213.700

329.660

223.725

 

 

TOTAL                                     (A)

23533.320

18587.450

14803.501

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Operative Expenses

12788.040

9944.640

8096.509

 

 

Employees Remuneration

3572.000

2863.810

2210.510

 

 

Other Expenses

3.280

3.450

5.803

 

 

Administrative Expenses

3186.860

2633.370

2065.738

 

 

TOTAL                                     (B)

19550.180

15445.270

12378.560

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

3983.140

3142.180

2424.941

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

587.320

377.470

223.160

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

3395.820

2764.710

2201.781

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

702.580

543.060

439.203

 

 

 

 

 

Less

EXTRAORDINARY ITEM

0.000

0.000

40.191

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

2693.240

2221.650

1722.387

 

 

 

 

 

Less

TAX                                                                  (H)

876.060

702.010

541.694

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

1817.180

1519.640

1180.693

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

1474.070

1208.760

1247.923

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

1000.000

750.000

750.000

 

 

Dividend

467.670

432.500

401.602

 

 

Tax on Dividend

75.860

71.830

68.255

 

 

Transfer to Debenture Redemption Reserve

100.000

0.000

0.000

 

BALANCE CARRIED TO THE B/S

1647.720

1474.070

1208.760

 

 

 

 

 

 

Earnings Per Share (Rs.)

14.66

12.31

--

 

 


QUARTERLY RESULTS

 

PARTICULARS

30.06.2011

 

30.09.2011

31.12.2011

31.03.2012

 

1st Quarter

2nd Quarter

3rd Quarter

4th Quarter

Net Sales

6410.100

6997.500

7147.500

7445.600

Total Expenditure

5350.800

5832.500

5963.800

6245.300

PBIDT (Excl OI)

1059.300

1165.000

1183.700

1200.300

Other Income

46.600

69.500

103.800

64.600

Operating Profit

1105.900

1234.500

1287.500

1264.900

Interest

149.400

177.600

126.70

154.900

PBDT

956.500

1056.900

1160.800

1110.000

Depreciation

197.700

227.900

242.500

240.80

Profit Before Tax

758.800

829.000

918.300

869.200

Tax

246.100

271.400

271.800

276.000

Profit After Tax

512.700

557.600

646.500

593.200

Net Profit

512.700

557.600

646.500

593.200

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

7.72

8.17

7.97

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

11.54

12.16

11.81

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.36

10.75

12.60

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.15

0.14

0.12

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.78

0.83

0.62

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.11

2.18

2.01

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No 

5) Type of Business

Yes

6) Line of Business

Yes

7) Promoter’s background

No 

8) No. of employees

No 

9) Name of person contacted

No 

10) Designation of contact person

No 

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No 

15) Capital in the business

Yes

16) Details of sister concerns

Yes

17) Major suppliers

No

18) Major customers

No 

19) Payments terms

No 

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter involved in

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

No 

 

RESULTS OF OPERATIONS:

 

The gross revenue of the company increased to Rs. 23533 million compared to Rs. 18587 millions in the previous year, registering an impressive growth of 27%. The profit after tax for the year increased by 20% to Rs. 1817 million compared to Rs. 1520 millions in the previous year.

 

During the year, the consolidated gross revenue of the company increased to Rs. 26240 millions compared to Rs. 20587 millions in the previous year, registering an impressive growth of 27%. Net profit after minority interest for the group increased to Rs. 1839 millions from Rs. 1376 millions representing a growth of 34%.

 

FINANCIAL PERFORMANCE:

 

·         FY12 Revenues Rs 31 475 up 20 8% yoy)

·         FY12 Consolidated EBITDA of Rs. 5131 millions (up 22.5% yoy)

·         FY12 Consolidated EBITDA margin at 16.3% as compared to 16.1% in FY11

·         Consolidated PAT of Rs. 2194 millions (up 19.3% yoy);

·         Q4 FY12 Consolidated revenues of Rs. 8572 millions (up 20.4%)

·         Q4 FY12 Consolidated EBITDA of Rs. 1309 millions (up 25.9%)

·         Q4 FY12 Consolidated EBITDA margin at 15.3% as compared to 14.6% in FY11

 

KEY OPERATIONAL HIGHLIGHTS:

 

·         Hyderabad cluster continues to display strong growth. Average occupancy at 577 beds (62% utilization on 930 beds) as compared to 526 beds (65% utilization on 809 beds) in FY12. Strong volume growth on focus COE’s like Cardiology (36%), Neurosciences (23%), Gastro (27%), Transplants (64%) and Oncology (30%).

 

·         Bhubaneswar occupancy at 144 beds (65% utilization on an increased capacity of 220 beds) as compared to 78 beds in FY12, due to increased patient footfalls and admissions. Q4FY12 EBITDA margins at 16% from 5% in the same period last year.

 

·         SAP continues its EBITDA expansion trajectory despite adding 74 new stores in Q4. Gross stores added in Q4 FY12 81 and stores closed 7. Added 263 stores and closed 98 stores in FY12.

 

·         Apollo Munich achieved a Gross Written Premium of Rs. 4759 millions against Rs. 2835 millions achieved during the same period in the previous year representing a growth of 68%. The incurred claim ratio improved to 58 % (FY12) from 62 % (FY11) due to prudent underwriting and improved pricing.

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Medical Equipments and Surgical Instruments

·         Electrical Installation and Generators

·         Office Equipment

·         Furniture and Fixtures

·         Boilers

·         Vehicles

·         Computer Software

 

NEWS:

 

APOLLO HOSPITALS GROUP - THE ONLY HEALTHCARE ORGANIZATION IN THE WORLD TO BE DECLARED AS A WINNER OF G20 CHALLENGE ON INCLUSIVE BUSINESS INNOVATION BY THE GROUP OF 20!

 

19.06.2012

 

The Group of 20 announced the winners of the G20 Challenge on Inclusive Business Innovation, a global competition managed by IFC, a member of the World Bank Group at the G20 Summit in Los Cabos, Mexico, on June 18, 2012.

Apollo Hospitals was declared a winner (the only healthcare organization in the World) for it's Reach Hospitals initiative. Apollo Reach Hospitals is an initiative of the Apollo Hospitals Group to take quality tertiary healthcare to semi-urban and rural areas in the country. Apollo Hospitals Group provides specialized medical services in India's underserved rural areas and smaller towns

 

Apollo Reach Hospitals were created to bridge the healthcare access gap by making specialized healthcare available to the poorest people. The Apollo Reach Hospital in Karimnagar, Andhra Pradesh was chosen by Apollo Hospitals Group to represent its model in the G20 Challenge. Dr. Manmohan Singh, Hon'ble Prime Minister of India inaugurated this facility in 2008. This pioneering initiative of the Apollo Hospitals Group aims to reach world-class healthcare to semi urban and rural India. Apollo Reach has a wide array of offerings apart from regular medical facilities, including pharmacies to insurance services.

Ms Preetha Reddy, Managing Director, Apollo Hospitals Group said, "We are extremely proud to be recognized by the G20 for our efforts in bringing about a visible change in the lives of people at the bottom of the pyramid (BOP). More than 25 percent of families in India live on the margins, spending less than US$70 a month on goods and services. Many of their basic needs go unmet, and they have little access to clean water, financial services, and education. More than 85 percent of these families live outside major cities. Unfortunately, most tertiary healthcare facilities in India are located in major metropolitan areas – meaning that most Indians have little or no access to specialized healthcare services. We consider it our responsibility to extend the same kind of healthcare services and facilities to smaller towns. This is our way of reinvesting in the ecosystem and contributing to the Indian society at large."

Apollo Reach Hospitals operate in less-developed population centres – termed Tier II cities – and offer medical care at rates up to 30 percent lower than other major hospitals. Within Reach Hospitals, low-income care is subsidized by services sold to high-income patients from the same area.

The world's leading economies launched the G20 Challenge to rapidly expand commercially viable businesses that serve the large numbers of low-income people that constitute the base of the global economic pyramid. Its goal is to identify, showcase, and support innovative business models that can be replicated across developing countries.

The online competition was launched to find the best examples worldwide of businesses in developing countries that provide critical goods, services, and livelihood opportunities in financially, environmentally, and socially sustainable ways to those living at the bottom of the pyramid, called 'inclusive businesses'. The G20 Challenge on Inclusive Business Innovation recognized businesses with innovative, scalable, and commercially viable ways of working with low-income people in developing countries.

An independent judging panel - including representatives from the G20, the private sector, academia, foundations, and International Finance Institutions - selected 15 Challenge winners based on the following criteria:

·                     Innovation

·                     Development results

·                     Potential for growth, including replication of the business model in other markets

·                     Financial sustainability

·                     Environmental and social sustainability

"The winners demonstrate that commercially viable companies can also provide economic opportunities for poor people-along with better access to clean water, electricity, health care, education, housing, phone services, and financial services." said Lars Thunell, IFC Executive Vice President and CEO. "They provide impressive models for others to follow."

The awards were presented by Ambassador Rogelio Granguillhome, Chair of the G20 Development Working Group, Dr. Edmund Duckwitz, Ambassador of Germany to Mexico and Mr. Lars Thunell, Executive Vice President of IFC at a grand award ceremony on June 18, 2012.

APOLLO HOSPITALS PARTNERS WITH NATIONAL SKILL DEVELOPMENT CORP. (NSDC), A PUBLIC-PRIVATE PARTNERSHIP TO PROMOTE SKILLS AMONG INDIANS.

12.06.2012

 

Apollo Hospitals has formed a subsidiary to impart healthcare-related training to 392,000 people in 10 years. NSDC has agreed to buy a stake in Apollo Med Skills Limited, a Unit of the Apollo Hospitals Group.

The investment on the project will be around Rs.390.000 Millions, of which NSDC will loan Rs. 251.300 Millions to Apollo Med Skills. Apollo will contribute Rs.98.800 Millions. NSDC will also buy a 27% stake in Apollo Med Skills for Rs.36.500 Millions.

Dr. K. Prabhakar, Chief Executive Officer of Apollo Med Skills, said the company is entering the sector because it realises the requirement for trained manpower. Dr. Prabhakar said the group formed the unit towards the end of 2011 and was engaged with NSDC for the partnership. "We have now got their board approval," he said.

The company will train people in subjects such as medical lab technology, dialysis and non-invasive cardiac courses, radiology and imaging, and operation theatre technology. It will also train doctors and nurses to update their skills.

Ms.S angita Reddy, executive director of operations at Apollo Hospitals, will oversee the work of the training subsidiary as a director.

NSDC representative said. "Since they are an established player, we can expect complete commitment from them."

The company plans to set up about 47 centres in Andhra Pradesh, Tamil Nadu, Bihar, Orissa, Jharkhand, Karnataka and West Bengal. "Since, we have partnered with NSDC, we can use some government school buildings for running classes, especially in the evenings," Dr. Prabhakar said.

Apollo will also find jobs for the trained people in its hospitals and other healthcare centres.

 

APOLLO HOSPITALS CHENNAI ORGANIZES ACTIVITIES TO CREATE AWARENESS ON ORAL AND LUNG CANCER ON THE OCCASION OF "WORLD NO TOBACCO" DAY ON MAY 31ST.

 

31.05.2012

 

Apollo Cancer Institute, Chennai urges people to kick tobacco chewing and smoking habits and organizes activities in collaboration with Madras Road Transport Corporation to create awareness on Oral and Lung cancer on the occasion of "World No Tobacco" day on May 31st.

"World No Tobacco" Day (WNTD) is observed around the world every year on May 31. It is meant to encourage a 24-hour period of abstinence from all forms of tobacco consumption across the globe. The day is further intended to draw global attention to the widespread prevalence of tobacco use and to negative health effects, which currently lead to 5.4 million deaths worldwide annually.

According to WHO tobacco is the second major cause of death worldwide. For creating the awareness for oral and lung cancer and also the harmful effects of tobacco usage, Apollo Speciality Cancer Hospital arranged a series of activities, throughout the no tobacco campaign week.

With the mission of making Chennai a healthy city, Apollo Cancer Institute, Chennai have collaborated with Madras Road Transport Corporation (MTC) and organized series of activities on this occasion. An awareness talk and Pulmonary function tests were organized for the staff of Madras Transport Corporation. Usually the drivers from MTC are more prone to hazards of pollution and they are also in the forefront of active as well as passive smoking and chewing tobacco, in order to reduce the stress that they come across in their day today work. Keeping this in mind, Apollo Cancer Institute has taken the initiative to educate the staff of MTC against the harmful effects of tobacco and smoking. More than 500 employees from Madras Transport Corporation are expected to benefit from this test conducted.

Apart from this major campaign Apollo has also initiated various activities, focused on PSUs, Corporates to create awareness on the harmful effects of smoking and tobacco. Again, PFT test is being conducted and awareness talks are organised at these Corporates to highlight on the need for a Healthy Life style and importance of regular cancer screening. Around 10 Corporates have been screened throughout the week, which includes screening of more than 1000 people. The workforce which includes more than 5000 people, have been given awareness on the hazards of smoking and chewing tobacco through awareness talks by Cancer Specialists from Apollo Speciality Cancer Hospital. The Corporates have also joined wholeheartedly in this noble initiative from Apollo Hospitals.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.99

UK Pound

1

Rs.88.97

Euro

1

Rs.71.57

 

 

INFORMATION DETAILS

 

Report Prepared by :

TPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

8

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

8

--CREDIT LINES

1~10

8

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

71

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.